EBMT 2012 - Addressing Two Critical Early Complications of HSCT:

Current and Future Concepts for Prevention and Treatment of VOD and GvHD

Gentium Sponsored Satellite Symposium at the European Group for Blood and Marrow Transplantation (EBMT) Meeting, Geneva, Switzerland, April 1, 2012

Lecture 1 - Pathophysiology, Incidence and Outcome of VOD after HSCT: What have we Learned in 30 years?

Enric Carreras, Hospital Clinic Barcelona, Barcelona, Spain

Treatment Strategies - EBMT 2012 - Lecture 2 - Therapy for Established VOD: An Update on Defibrotide Treatment Studies 

Dietger Niederwieser, University of Leipzig, Leipzig, Germany.

Treatment Strategies - EBMT 2012 - Lecture 3 - Acute GvHD: What are the Causes and Consequences at a Cellular Level?

Ernst Holler, University Medical Center, Regensburg, Germany.

Treatment Strategies - EBMT 2012 - Lecture 4 - Prevention of VOD and GvHD: What did we learn from the VOD-defibrotide prevention trial?

Selim Corbacioglu, Children's Hospital, Regensburg, Germany

Back to the Hematology home page